Should We Screen for Janus Kinase 2 V617F Mutation in Cerebral Venous Thrombosis?

Publisher： Karger

E-ISSN： 1421-9786|44|3-4|97-104

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.44, Iss.3-4, 2017-06, pp. : 97-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

JAK2V617F Mutation Associated with Cerebral Venous Thrombosis: A Report of Five Cases

By  

Cerebrovascular Diseases, Vol. 29, Iss. 2, 2009-12 ,pp. : 206-209

Karger

Access to resources Recommend Favorite

JAK2V617F Mutation in Patients with Splanchnic Vein Thrombosis

By Xavier Sandra   Gadelha Telma   Pimenta Glicínia   Eugenio Angela   Ribeiro Daniel   Gomes Fernanda   Bonamino Martin   Zalcberg Ilana   Spector Nelson  

Digestive Diseases and Sciences, Vol. 55, Iss. 6, 2010-06 ,pp. : 1770-1777

Springer Publishing Company

Access to resources Recommend Favorite

Lupus anticoagulant, Factor V Leiden, and methylenetetrahydrofolate reductase gene mutation in a lupus patient with cerebral venous thrombosis

By Uthman Imad   Khalil Ismail   Sawaya Raja   Taher Ali  

Clinical Rheumatology, Vol. 23, Iss. 4, 2004-08 ,pp. : 362-363

Springer Publishing Company

Access to resources Recommend Favorite

Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis

By van Dunné F.M.  

Human Reproduction, Vol. 20, Iss. 3, 2005-03 ,pp. : 802-806

Oxford University Press

Access to resources Recommend Favorite

Hyperthyroidism and Cerebral Venous Thrombosis

By  

European Neurology, Vol. 54, Iss. 2, 2005-10 ,pp. : 78-80

Karger

Access to resources Recommend Favorite